Timothy Chan, MD, PhD, Cleveland Clinic (IMAGE)
Caption
Cleveland Clinic received a $7.9 million five-year grant from the National Cancer Institute to form one of three national centers as part of the newly established Radiation Oncology-Biology Integration Network (ROBIN). Timothy Chan, M.D., Ph.D., Chair of the Center for Immunotherapy and Precision Immuno-Oncology, will serve as primary investigator of Cleveland Clinic’s ROBIN center.
Credit
Cleveland Clinic
Usage Restrictions
None
License
Original content